BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 24939737)

  • 1. Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract.
    Barrera J; Chambliss KL; Ahmed M; Tanigaki K; Thompson B; McDonald JG; Mineo C; Shaul PW
    Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E345-54. PubMed ID: 24939737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of genistein in combination with conjugated estrogens on endometrial hyperplasia and metabolic dysfunction in ovariectomized mice.
    Kim JH; Kim YJ
    Endocr J; 2015; 62(6):531-42. PubMed ID: 25877295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.
    Sharifi M; Lewiecki EM
    Expert Rev Clin Pharmacol; 2014 May; 7(3):281-91. PubMed ID: 24580081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-selective estrogen complexes for postmenopausal women.
    Mirkin S; Komm BS
    Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
    Pickar JH; Mirkin S
    Menopause Int; 2010 Sep; 16(3):121-8. PubMed ID: 20956688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
    Palacios S; Currie H; Mikkola TS; Dragon E
    Maturitas; 2015 Apr; 80(4):435-40. PubMed ID: 25684082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats.
    Komm BS; Vlasseros F; Samadfam R; Chouinard L; Smith SY
    Bone; 2011 Sep; 49(3):376-86. PubMed ID: 21658483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trials.
    Pinkerton JV; Abraham L; Bushmakin AG; Cappelleri JC; Racketa J; Shi H; Chines AA; Mirkin S
    J Womens Health (Larchmt); 2014 Jan; 23(1):18-28. PubMed ID: 24206058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal bleeding/spotting with conjugated estrogens/bazedoxifene, conjugated estrogens/medroxyprogesterone acetate, and placebo.
    Kagan R; Abreu P; Andrews E
    Postgrad Med; 2018 Nov; 130(8):687-693. PubMed ID: 30280946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bazedoxifene and conjugated estrogen combination maintains metabolic homeostasis and benefits liver health.
    Chen KLA; Zhao YC; Hieronymi K; Smith BP; Madak-Erdogan Z
    PLoS One; 2017; 12(12):e0189911. PubMed ID: 29267318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.
    Komm BS; Mirkin S; Jenkins SN
    Steroids; 2014 Nov; 90():71-81. PubMed ID: 24929044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trial.
    Pinkerton JV; Harvey JA; Lindsay R; Pan K; Chines AA; Mirkin S; Archer DF;
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E189-98. PubMed ID: 24438370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonnuclear Estrogen Receptor Activation Improves Hepatic Steatosis in Female Mice.
    Chambliss KL; Barrera J; Umetani M; Umetani J; Kim SH; Madak-Erdogan Z; Huang L; Katzenellenbogen BS; Katzenellenbogen JA; Mineo C; Shaul PW
    Endocrinology; 2016 Oct; 157(10):3731-3741. PubMed ID: 27552247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in menopausal therapy: the tissue-selective estrogen complex.
    Moore A
    J Am Assoc Nurse Pract; 2013 Mar; 25(3):126-33. PubMed ID: 24218199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprela, a single tablet formulation of bazedoxifene and conjugated equine estrogens (Premarin) for the potential treatment of menopausal symptoms.
    Stovall DW
    Curr Opin Investig Drugs; 2010 Apr; 11(4):464-71. PubMed ID: 20336595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy.
    Bachmann G; Bobula J; Mirkin S
    Climacteric; 2010 Apr; 13(2):132-40. PubMed ID: 19863455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause.
    Tella SH; Gallagher JC
    Expert Opin Pharmacother; 2013 Dec; 14(17):2407-20. PubMed ID: 24093499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy.
    Pickar JH; Yeh IT; Bachmann G; Speroff L
    Fertil Steril; 2009 Sep; 92(3):1018-1024. PubMed ID: 19635613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile.
    Lobo RA; Pinkerton JV; Gass MLS; Dorin MH; Ronkin S; Pickar JH; Constantine G
    Fertil Steril; 2009 Sep; 92(3):1025-1038. PubMed ID: 19635615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.